Marco Mravic

Marco Mravic

Auto-generated profile, based on publicly available information

Marco Mravic

Department of Integrative Structural and Computational Biology, The Scripps Research Institute

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2019 in Science
Verified
Journal Article
Closed access
PDF file
MMMarco Mravic
Marco Mravic
JTJessica L. Thomaston
Jessica L. Thomaston
MTMaxwell Tucker
Maxwell Tucker
PSPaige E. Solomon
Paige E. Solomon
LLLijun Liu
Lijun Liu
WDWilliam F. DeGrado
William F. DeGrado
Precise packing for membrane proteins: Although nonpolar amino acid side chains pack efficiently in membrane proteins, it has been difficult to determine how much this contributes to membrane protein stability. Designed membrane proteins have largely relied on other stabilizing interactions such as metal-ligand interactions and hydrogen bonds. Mravic et al. uncovered a steric packing code underlying the folding of the natural protein phospholamban, which they used to design stable membrane proteins with nonpolar interfaces. They suggest that packing of nonpolar residues plays a role in the folding and stability of many membrane proteins. Science , this issue p. 1418

6 April 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MMMarco Mravic
Marco Mravic
BPBruno Péault
Bruno Péault
AJAaron W. James
Aaron W. James
The development of tissue engineering and regeneration constitutes a new platform for translational medical research. Effective therapies for bone engineering typically employ the coordinated manipulation of cells, biologically active signaling molecules, and biomimetic, biodegradable scaffolds. Bone tissue engineering has become increasingly dependent on the merging of innovations from each of these fields, as they continue to evolve independently. This foreword will highlight some of the most recent advances in bone tissue engineering and regeneration, emphasizing the interconnected fields of stem cell biology, cell signaling biology, and biomaterial research. These include, for example, novel methods for mesenchymal stem cell purification, new methods of Wnt signaling pathway manipulation, and cutting edge computer assisted nanoscale design of bone scaffold materials. In the following special issue, we sought to incorporate these diverse areas of emphasis in order to reflect current trends in the field.

13 March 2024 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
MMMarco Mravic
Marco Mravic
LHLi He
Li He
HKHuong T. Kratochvil
Huong T. Kratochvil
HHHailin Hu
Hailin Hu
SNSarah Elizabeth Nick
Sarah Elizabeth Nick
WDWilliam F. DeGrado
William F. DeGrado
Transmembrane (TM) domains as simple as a single span can perform complex biological functions using entirely lipid-embedded chemical features. Computational design has the potential to generate custom tool molecules directly targeting membrane proteins at their functional TM regions. Thus far, designed TM domain-targeting agents have been limited to mimicking the binding modes and motifs of natural TM interaction partners. Here, we demonstrate the design of de novo TM proteins targeting the erythropoietin receptor (EpoR) TM domain in a custom binding topology competitive with receptor homodimerization. The TM proteins expressed in mammalian cells complex with EpoR and inhibit erythropoietin-induced cell proliferation. In vitro, the synthetic TM domain complex outcompetes EpoR homodimerization. Structural characterization reveals that the complex involves the intended amino acids and agrees with our designed molecular model of antiparallel TM helices at 1:1 stoichiometry. Thus, membrane protein TM regions can now be targeted in custom-designed topologies.

17 June 2015 in International Journal of Surgical Pathology
Verified
Journal Article
Open access
PDF file
JSJIA SHEN
JIA SHEN
SSSwati Shrestha
Swati Shrestha
YYYu-Hsin Yen
Yu-Hsin Yen
GAGreg Asatrian
Greg Asatrian
MMMarco Mravic
Marco Mravic
AJAaron W. James
Aaron W. James
Introduction. Perivascular soft tissue tumors are relatively uncommon neoplasms of unclear line of differentiation, although most are presumed to originate from pericytes or modified perivascular cells. Among these, glomus tumor, myopericytoma, and angioleiomyoma share a spectrum of histologic findings and a perivascular growth pattern. In contrast, solitary fibrous tumor (previously termed hemangiopericytoma) was once hypothesized to have pericytic differentiation. Methods. Here, we systematically examine pericyte immunohistochemical markers among glomus tumor (including malignant glomus tumor), myopericytoma, angioleiomyoma, and solitary fibrous tumor. Immunohistochemical staining and semiquantification was performed using well-defined pericyte antigens, including αSMA, CD146, and PDGFRβ. Results. Glomus tumor and myopericytoma demonstrate diffuse staining for all pericyte markers, including immunohistochemical reactivity for αSMA, CD146, and PDGFRβ. Malignant glomus tumors all showed some degree of pericyte marker immunoreactivity, although it was significantly reduced. Angioleiomyoma shared a similar αSMA + CD146 + PDGFRβ+ immunophenotype; however, this was predominantly seen in the areas of perivascular tumor growth. Solitary fibrous tumors showed patchy PDGFRβ immunoreactivity only. Discussion. In summary, pericyte marker expression is a ubiquitous finding in glomus tumor, myopericytoma, and angioleiomyoma. Malignant glomus tumor shows a comparative reduction in pericyte marker expression, which may represent partial loss of pericytic differentiation. Pericyte markers are essentially not seen in solitary fibrous tumor. The combination of αSMA, CD146, and PDGFRβ immunohistochemical stainings may be of utility for the evaluation of pericytic differentiation in soft tissue tumors.

1 May 2018 in Protein Engineering, Design and Selection
Verified
Journal Article
Open access
PDF file
MMMarco Mravic
Marco Mravic
HHHailin Hu
Hailin Hu
ZLZhenwei Lu
Zhenwei Lu
JBJoel S Bennett
Joel S Bennett
CSCharles Sanders
Charles Sanders
WDWilliam F DeGrado
William F DeGrado
Computationally designed transmembrane α-helical peptides (CHAMP) have been used to compete for helix–helix interactions within the membrane, enabling the ability to probe the activation of the integrins αIIbβ3 and αvβ3. Here, this method is extended towards the design of CHAMP peptides that inhibit the association of the α5β1 transmembrane (TM) domains, targeting the Ala–X3–Gly motif within α5. Our previous design algorithm was performed alongside a new workflow implemented within the widely used Rosetta molecular modeling suite. Peptides from each computational approach activated integrin α5β1 but not αVβ3 in human endothelial cells. Two CHAMP peptides were shown to directly associate with an α5 TM domain peptide in detergent micelles to a similar degree as a β1 TM peptide does. By solution-state nuclear magnetic resonance, one of these CHAMP peptides was shown to bind primarily the integrin β1 TM domain, which itself has a Gly–X3–Gly motif. The second peptide associated modestly with both α5 and β1 constructs, with slight preference for α5. Although the design goal was not fully realized, this work characterizes novel CHAMP peptides activating α5β1 that can serve as useful reagents for probing integrin biology.

3 June 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RLRustem Litvinov
Rustem Litvinov
MMMarco Mravic
Marco Mravic
HZHua Zhu
Hua Zhu
JWJohn W. Weisel
John W. Weisel
WDWilliam F. DeGrado
William F. DeGrado
JBJoel S. Bennett
Joel S. Bennett
Lateral transmembrane (TM) helix–helix interactions between single-span membrane proteins play an important role in the assembly and signaling of many cell-surface receptors. Often, these helices contain two highly conserved yet distinct interaction motifs, arranged such that the motifs cannot be engaged simultaneously. However, there is sparse experimental evidence that dual-engagement mechanisms play a role in biological signaling. Here, we investigate the function of the two conserved interaction motifs in the TM domain of the integrin β3-subunit. The first motif uses reciprocating “large-large-small” amino acid packing to mediate the interaction of the β3 and αIIb TM domains and maintain the inactive resting conformation of the platelet integrin αIIbβ3. The second motif, S-x3-A-x3-I, is a variant of the classical “G-x3-G” motif. Using site-directed mutagenesis, optical trap-based force spectroscopy, and molecular modeling, we show that S-x3-A-x3-I does not engage αIIb but rather mediates the interaction of the β3 TM domain with the TM domain of the αv-subunit of the integrin αvβ3. Like αIIbβ3, αvβ3 on circulating platelets is inactive, and in the absence of platelet stimulation is unable to interact with components of the subendothelial matrix. However, disrupting any residue in the β3 S-x3-A-x3-I motif by site-directed mutations is sufficient to induce αvβ3 binding to the αvβ3 ligand osteopontin and to the monoclonal antibody WOW-1. Thus, the β3-integrin TM domain is able to engage in two mutually exclusive interactions that produce alternate α-subunit pairing, creating two integrins with distinct biological functions. Significance Besides anchoring proteins in membranes, transmembrane (TM) helices facilitate the assembly of multisubunit proteins. Often, TM helices contain several TM–helix interaction sequences, arranged such that they cannot be simultaneously engaged. The TM helix of the β3-integrin subunit contains two different sequences that it uses to interact with two different α-subunits, one with αIIb and the other with αv. Because integrins have distinct biological functions, the ability of a single TM helix to use different sequences to interact with different partners likely contributes to this functional specificity. Thus, the ability to achieve binding on two faces of a single TM helix provides a mechanism to evolve new binding partners for integrins and likely other membrane proteins as well.